Day Zero Diagnostics

0 followers


The future of infectious disease diagnostics starts at Day Zero. By using whole-genome sequencing (WGS) and the proprietary enabling technologies, Day Zero is creating a new class of sequencing-based in-vitro diagnostics that generates clinically actionable data at scale.

Industries

Employees

51-200

Links

Org chart

Jong Lee
CEO & Cofounder

Jong Lee

Collapse
Miriam Huntley
Co Founder And CTO
Doug Kwon
Chief Scientific Officer
Melis Anahtar
Co-founder
Dougal Maclaurin
Scientific Co-founder
Dekel Gelbman
Senior Vice President, Business Development And Partnerships
Rene Robert
VP, Product Realization
Melodie Domurad
VP, Medical Affairs
Manoj Nair
Vice President, Molecular Assay Development